What is the efficacy of the hyper-CVAD chemotherapy regimen followed by ASCT in the treatment of mantle cell lymphoma (MCL)?

Updated: Mar 15, 2019
  • Author: Muhammad Rashid Abbasi, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print


Studies have shown that ASCT either as frontline consolidation or in the context of relapse provides high response rates and may improve disease-free survival. Unfortunately, this therapy is still typically associated with a continuous pattern of relapse.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!